Chi Advisors LLC Portfolio Holdings

Chi Advisors LLC

  • $203 Million
  • Q3 2023

Chi Advisors LLC has filed its 13F form on November 13, 2023 for Q3 2023 where it was disclosed a total value porftolio of $203 Million distributed in 28 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Pliant Therapeutics, Inc. with a value of $52.3M, Repare Therapeutics Inc. with a value of $35.8M, Cullinan Oncology, Inc. with a value of $30.9M, Larimar Therapeutics, Inc. with a value of $13.5M, and Keros Therapeutics, Inc. with a value of $13M.

Examining the 13F form we can see an decrease of $63.2M in the current position value, from $266M to 203M.

Chi Advisors LLC is based out at New York, NY

Below you can find more details about Chi Advisors LLC portfolio as well as his latest detailed transactions.

Portfolio value $203 Million
Healthcare: $198 Million
ETFs: $4.64 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$620M
$52.3 Million 25.76% of portfolio
3,014,199
Q3 2023 Reduced 3.3%
$119M
$35.8 Million 17.66% of portfolio
2,966,674
Q3 2023 Reduced 1.07%
$574M
$30.9 Million 15.23% of portfolio
3,414,189
Q2 2023 Added 1.93%
$269M
$13.5 Million 6.65% of portfolio
3,414,468
Q2 2023 Added 24.33%
$1.39B
$13 Million 6.41% of portfolio
407,633
Q3 2023 Added 1.37%
$61.6M
$9.44 Million 4.65% of portfolio
2,180,934
Q3 2023 Added 2.78%
$3.25B
$7.66 Million 3.78% of portfolio
215,000
Q3 2023 Added 152.94%
$139M
$5.57 Million 2.75% of portfolio
2,829,712
Q1 2022 Reduced 6.42%
$110M
$5.33 Million 2.63% of portfolio
1,270,027
Q3 2023 Added 6.28%
$5.66B
$4.66 Million 2.3% of portfolio
92,888
Q3 2023 New
$0
$4.64 Million 2.28% of portfolio
225,000
Q3 2023 Reduced 30.77%
$118M
$3.93 Million 1.94% of portfolio
1,002,007
Q3 2023 Added 17.61%
$1.82B
$3.42 Million 1.69% of portfolio
60,000
Q3 2023 New
$73.2M
$3.32 Million 1.64% of portfolio
864,822
Q2 2022 Added 1.4%
$37.8M
$2.27 Million 1.12% of portfolio
1,055,882
Q3 2021 New
$90.5M
$2.07 Million 1.02% of portfolio
720,000
Q3 2023 Reduced 4.0%
$0
$572,000 0.28% of portfolio
230,938
Q2 2023 New
$791M
$206,000 0.1% of portfolio
606,629
Q3 2023 Reduced 62.17%
Syros Pharmaceuticals Inc
-
$0 0.0% of portfolio
-
Q3 2023 Added 69.31%
Sagimet Biosciences Inc
-
$0 0.0% of portfolio
-
Q3 2023 New
Acelyrin Inc
-
$0 0.0% of portfolio
-
Q3 2023 Reduced 15.05%
Mineralys Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2023 New
Freeline Therapeutics Hldgs
-
$0 0.0% of portfolio
-
Q3 2023 Added 299.95%
Orchard Therapeutics PLC
-
$0 0.0% of portfolio
-
Q3 2023 Added 1,529.62%
Disc Medicine Inc
-
$0 0.0% of portfolio
-
Q3 2023 Reduced 80.02%

Summary

  • Portfolio
  • No. of Stocks 28
  • Current Value $203 Million
  • Prior Value $266 Million
  • Filing
  • Period Q3 2023
  • Filing Date November 13, 2023
  • Form Type 13F-HR
  • Activity in Q3 2023
  • New Purchases 4 stocks
  • Additional Purchases 8 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 8 stocks
Track This Portfolio

Track Chi Advisors LLC Portfolio

Follow Chi Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chi Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chi Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email